The retrospective clinicopathological characteristics of oligodendroglial
tumors were investigated in patients who underwent surgery,
radiotherapy, and/or
chemotherapy. Regarding
oligodendroglioma and oligoastrocytoma without
malignancy, patients who had undergone
radiation therapy at a total dose of 40-50Gy had relatively long postoperative survival. Of these 15 patients, 6 showed signs of recurrence, and after additional treatment, 5 patients are still alive. On the other hand, regarding anaplastic oligodendroglial
tumors, patients with anaplastic oligoastrocytoma responded well to
combination chemotherapy with
interferon beta, nitrosourea derivatives (
ACNU/
MCNU), and
radiation therapy (referred to as IAR/IMR) and survived longer than patients with
anaplastic oligodendroglioma. In conclusion, patients with oligodendroglial
tumors could survive longer by treatment involving surgery and
radiotherapy. As for
malignancy, cases of anaplastic oligoastrocytoma could be effectively treated by adjuvant
therapy using IAR/IMR after surgery, but in cases of
anaplastic oligodendroglioma, the response to IAR/IMR was not good, and another strategy of treatment should be recommended.